Celldex Therapeutics buy Wells Fargo & Company
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€32.67
Performance (%)
6.52%
Price
20.02.26
€19.80
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 6.52%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 1.020% | 1.020% |
| iShares Core DAX® | 1,43 % | 2,63 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % |
| iShares S&P 500 | 1,92 % | 1,16 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat